Stay updated on Tepotinib Phase II Clinical Trial
Sign up to get notified when there's something new on the Tepotinib Phase II Clinical Trial page.
Latest updates to the Tepotinib Phase II Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedAdded clarifying text about the Publications section: some publications are provided voluntarily and relate to the results, while others are automatically filled from PubMed. Revision: v3.3.2.SummaryDifference0.1%
- Check20 days agoChange DetectedDeleted a general government funding and operating status notice that previously appeared on the page; it did not affect the trial details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check34 days agoChange DetectedSubstantive content did not change; the two screenshots show the same Study Details page for NCT02864992 with no additions or deletions to the core content.SummaryDifference0.2%
- Check63 days agoChange DetectedAdded a government funding lapse notice and a v3.2.0 version tag, replacing the prior v3.1.0.SummaryDifference2%
- Check70 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.0%
- Check84 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2 and the Back to Top element was removed. Overall, a minor maintenance update with no substantive changes to core content, pricing, or stock.SummaryDifference0.1%
Stay in the know with updates to Tepotinib Phase II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tepotinib Phase II Clinical Trial page.